Fortitude Family Office, LLC Argenx Se Transaction History
Fortitude Family Office, LLC
- $280 Billion
- Q4 2024
A detailed history of Fortitude Family Office, LLC transactions in Argenx Se stock. As of the latest transaction made, Fortitude Family Office, LLC holds 3 shares of ARGX stock, worth $1,741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 3
-0.0%
Holding current value
$1,741
Previous $1.63 Million
13.47%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
434Shares Held
29.2MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.2 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.78 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.34 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.04 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$719 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.1B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...